Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Fazirsiran in the Treatment of Alpha-1 Antitrypsin Deficiency?associated Liver Disease With Metavir
Sponsored by PPD Investigator Services, LLC.
Active
$1.6M Funding
3 People
External
Related Topics
clinical trial,
liver disease,
alpha-1 antitrypsin,
treatment,
safety
People
Jason Gass
(CD)
College of Medicine - Tucson
﹒Research Data Support Specialist II
Kirsten Anderson
(CD)
Az Health Sciences Division
﹒Research Compliance Administrator IV
Gustavo Cornejo
(CD)
Az Health Sciences Division
﹒Research Compliance Administrator III
